Liver transplantation of American veterans under FK 506 immunosuppression: a preliminary report.
作者信息
Mieles L A, Fung J J, Yokoyama I, McCauley J, Singh N, Todo S, Gordon R D, Starzl T E
机构信息
Department of Surgery, University of Pittsburgh School of Medicine, Pennsylvania.
出版信息
Transplant Proc. 1991 Dec;23(6):3016-8.
Abstract
摘要
相似文献
1
Liver transplantation of American veterans under FK 506 immunosuppression: a preliminary report.接受FK 506免疫抑制治疗的美国退伍军人肝移植：初步报告。
Transplant Proc. 1991 Dec;23(6):3016-8.
2
FK 506 versus cyclosporine in pediatric liver transplantation.儿童肝移植中FK506与环孢素的比较
Transplant Proc. 1991 Dec;23(6):3010-5.
3
FK 506 rescue therapy for refractory acute rejection in five liver recipients.FK506抢救治疗五例肝移植受者难治性急性排斥反应
Transplant Proc. 1991 Dec;23(6):3000-1.
4
Long-term insulin requirement after liver transplantation with FK 506 in American veterans.美国退伍军人肝移植后使用FK 506的长期胰岛素需求情况。
Transplant Proc. 1993 Feb;25(1 Pt 1):677-8.
5
Tacrolimus (FK 506) for rescue of chronic rejection following orthotopic liver transplantation.
Transplant Proc. 1996 Apr;28(2):1011-3.
6
A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine.一项关于在免疫抑制下使用FK 506与环孢素进行原位肝移植的随机试验。
Transplant Proc. 1991 Dec;23(6):2977-83.
7
Use of prostaglandin E1 in crossmatch-negative liver transplant recipients treated with FK 506.前列腺素E1在接受FK 506治疗的交叉配型阴性肝移植受者中的应用。
Transplant Proc. 1993 Jun;25(3):2381-5.
8
Therapy with FK 506 in pediatric liver recipients.
Transplant Proc. 1994 Feb;26(1):152-3.
9
Comparison of FK 506- and cyclosporine-based immunosuppression: FK 506 therapy significantly reduces the incidence of acute, steroid-resistant, refractory, and chronic rejection whilst possessing a comparable safety profile. European FK 506 Multicenter Liver Study Group.
Transplant Proc. 1995 Feb;27(1):45-9.
10
FK 506 primary immunosuppression following emergency liver transplantation for fulminant hepatic failure. European FK 506 Study Liver Group.
Transpl Int. 1994;7 Suppl 1:S64-9. doi: 10.1111/j.1432-2277.1994.tb01312.x.
引用本文的文献
1
Orthotopic liver transplantation in high-risk patients: risk factors associated with mortality and infectious morbidity.高危患者的原位肝移植：与死亡率和感染性发病率相关的危险因素
Transplantation. 1998 Feb 27;65(4):499-504. doi: 10.1097/00007890-199802270-00008.
2
A high incidence of native portal vein thrombosis in veterans undergoing liver transplantation.接受肝移植的退伍军人中，原发性门静脉血栓形成的发生率较高。
J Surg Res. 1996 Feb 1;60(2):333-8. doi: 10.1006/jsre.1996.0053.
3
Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial.他克莫司：自身免疫性慢性活动性肝炎的一种潜在新疗法：一项开放标签初步试验的结果
Am J Gastroenterol. 1995 May;90(5):771-6.
4
Decreased incidence of viral infections in liver transplant recipients. Possible effects of FK506?肝移植受者病毒感染发生率降低。FK506的可能作用？
Dig Dis Sci. 1994 Jan;39(1):15-8. doi: 10.1007/BF02090054.
本文引用的文献
1
The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients.环孢素及联合免疫抑制对肾移植受者移植后糖尿病发生率的影响。
Transplantation. 1987 Sep;44(3):376-81. doi: 10.1097/00007890-198709000-00010.
2
Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies.121例肝移植受者的巨细胞病毒及其他疱疹病毒感染：通过捐赠器官传播及OKT3抗体的影响
J Infect Dis. 1988 Jul;158(1):124-31. doi: 10.1093/infdis/158.1.124.
3
Posttransplant hyperglycemia. Increased incidence in cyclosporine-treated renal allograft recipients.
Transplantation. 1989 Feb;47(2):278-81.
4
Effect of cyclosporine on the endocrine and exocrine pancreas in kidney transplant recipients.
Am J Kidney Dis. 1988 Jul;12(1):11-7. doi: 10.1016/s0272-6386(88)80065-9.
5
Liver transplantation. Initial experience in the Veterans Administration.肝移植。退伍军人管理局的初步经验。
Dig Dis Sci. 1990 Jun;35(6):673-80. doi: 10.1007/BF01540165.
6
Initial two-year results of the Oregon Liver Transplantation Program.
Am J Surg. 1991 May;161(5):606-11. doi: 10.1016/0002-9610(91)90910-6.
7
Glycemia and insulin need following FK 506 rescue therapy in liver transplant recipients.肝移植受者接受FK 506挽救治疗后的血糖水平和胰岛素需求情况。
Transplant Proc. 1991 Feb;23(1 Pt 2):949-53.
8
Infections in adult liver transplant patients under FK 506 immunosuppression.接受FK 506免疫抑制治疗的成年肝移植患者的感染情况。
Transplant Proc. 1991 Feb;23(1 Pt 2):1501-3.
9
Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications.肝移植受者中因环孢素相关并发症而从环孢素转换为FK506治疗。
Transplant Proc. 1990 Feb;22(1):6-12.
10
Early trials with FK 506 as primary treatment in liver transplantation.FK506作为肝移植主要治疗手段的早期试验。
Transplant Proc. 1990 Feb;22(1):13-6.
Zotero 插件